Evidence map›Paper›PMID 29085965›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2018

PET and SPECT imaging of melanoma: the state of the art.

Weijun Wei, Emily B Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai

Abstract readReview
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical value of combinedFrontiers in medicine · 2025
    Article
  4. Amelanotic Melanoma-Biochemical and Molecular Induction Pathways.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Molecular Imaging of Melanoma VEGF-expressing Tumors through [Anti-cancer agents in medicinal chemistry · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  13. Review
  14. American journal of nuclear medicine and molecular imaging · 2022
    Article
  15. Development and characterization of CD54-targeted immunoPET imaging in solid tumors.European journal of nuclear medicine and molecular imaging · 2020
    Article
  16. Comparison of AlJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  17. Review
  18. Article
  19. CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  20. Noninvasive PET Imaging of T cells.Trends in cancer · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Weijun WeiDepartment of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600# Yishan Road, Shanghai, 200233, China.
Emily B EhlerdingDepartment of Medical Physics, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Key Laboratory of Molecular Imaging, No. 1277 Jiefang Ave, Wuhan, 430022, China. LXL30724@hotmail.com.
Quanyong LuoDepartment of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600# Yishan Road, Shanghai, 200233, China. lqyn@sh163.net.
Weibo CaiDepartment of Radiology, University of Wisconsin-Madison, Room 7137, 1111 Highland Avenue, Madison, WI, 53705-2275, USA. wcai@uwhealth.org.
University of Wisconsin–Madison · USHuazhong University of Science and Technology · CNShanghai Jiao Tong University · CNShanghai Sixth People's Hospital · CN

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
U.W. RADIOLOGICAL SCIENCES TRAINING PROGRAMT32CA009206 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Bryan Patrick Bednarz · 1985 to 2026
$12.1M
Chemistry-Biology Interface Training ProgramT32GM008505 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BLACKWELL, HELEN E. · 1993 to 2023
$9.8M
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneityR01CA205101 · NCI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI SKALA, MELISSA CAROLINE · 2016 to 2020
$1.9M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA205101NCI NIH HHS T32 CA009206NIGMS NIH HHS T32 GM008505NIH HHS 1R01CA205101NIH HHS P30CA014520NIH HHS T32GM008505
6 · The paper itself

Abstract

Melanoma represents the most aggressive form of skin cancer, and its incidence continues to rise worldwide.

Indexed as

AnimalsHumansMelanomaNeoplasm MetastasisProtein BindingRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonRadiopharmaceuticalsCancerImmunotherapyMelanomaMolecular imagingPositron emission tomography (PET)Single-photon emission computed tomography (SPECT)Theranostics

Identifiers

PMID29085965
PMCPMC5700861
OpenAlexW2767095706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.